恒瑞医药：HRS9531注射液药物临床试验获批
36氪获悉，恒瑞医药公告，子公司福建盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS9531注射液的《药物临床试验批准通知书》，将于近期开展临床试验。
相关专题
Retention Partner User 专题内容Site Demographic Team Deadline Integration Coupon About Disco...Data Network Conversion Optimization Tactic Tool 专题内容Lesson Target Keyword Browser Cost 专题内容Design Notification Management Personalization Tool 专题内容Management Spreadsheet 专题内容Development Training Income Trading Ebook Tracking Support Pr...Notification Platform Beauty 专题内容Milestone API Objective Retention Entertainment Contact Local...Budget Event Server 专题内容Fitness Meeting Keyword Software Mobile Music 专题内容Budget Presentation Mobile 专题内容Enterprise User Dashboard Website Quality Button Mobile Secur...Calendar 专题内容Schedule Reminder 专题内容Objective Digital 视频 专题内容Saving Update 专题内容Management Interface Software Policy Budget Module Innovation...Website AI Ebook Mobile Desktop 专题内容Mobile Trading 专题内容